Source
6 developments in the corpus
Latest
Everything in the corpus, newest first.
OCT 27, 2026 · JOURNAL ARTICLE
Advanced Materials
ABSTRACT Precise control over the phenotypic state of immune cells is critical for overcoming the limitations of on‐target off‐tumor toxicity and inefficient tumor infiltration in
ABSTRACT Abnormal metabolic reprogramming is a recognized hallmark of cancer, yet the clinical translation of cancer metabolic therapy (CMT) by conventional chemo‐drugs remains a g
OCT 13, 2026 · JOURNAL ARTICLE
Advanced Materials
ABSTRACT The fluctuating gastrointestinal milieu and its restrictive epithelial barrier represent critical challenges for the design of oral cancer vaccines. Nevertheless, leveragi
SEP 26, 2026 · JOURNAL ARTICLE
Advanced Materials
ABSTRACT Cuproptosis has recently been identified as a novel metabolic cell death pathway that holds great promise for cancer therapy. However, cuproptosis resistance developed by
SEP 24, 2026 · JOURNAL ARTICLE
Advanced Materials
The clinical application of tumor vascular obstruction therapy (TVOT) is mainly hindered by imprecise obstruction localization and transient embolic effects. We developed a biotact
SEP 9, 2026 · JOURNAL ARTICLE
Advanced Materials
This is an early-stage mechanistic study describing synthesis and proposed mechanism of a novel photosensitizer in prostate cancer, without clinical data or in vivo efficacy results reported.